• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD30 阳性转化性滤泡性淋巴瘤:两例报告及文献综述

CD 30-positive transformed follicular lymphoma: two case reports and literature review.

作者信息

Montes-Moreno Santiago, Climent Fina, González de Villambrosía Sonia, González Barca Eva M, Batlle Ana, Insunza Andrés, Pané-Foix María, Colorado Mercedes, Martin-Sánchez Guillermo, Espiga Carlos Richard, Conde Eulogio, Piris Miguel A

机构信息

Pathology and Hematology Departments, Hospital Universitario Marqués de Valdecilla/IDIVAL, Santander, Spain.

Pathology and Hematology Departments, ICO, Hospital Universitari de Bellvitge, Barcelona, Spain.

出版信息

Histopathology. 2015 Dec;67(6):918-22. doi: 10.1111/his.12733. Epub 2015 Jun 26.

DOI:10.1111/his.12733
PMID:25953530
Abstract

AIMS

Here we report two cases of follicular lymphoma that transformed to CD30 positive diffuse large B cell lymphoma and review the literature on this topic.

RESULTS

The first case represents an example of early transformation of conventional low-grade follicular lymphoma to CD30-positive large B cell lymphoma. Immunoglobulin (Ig)H and cytogenetic identity was demonstrated between both components. High-dose and auto-stem cell transplant (SCT) was applied and complete response was achieved. The second case represents an example of d'emblee transformation of intrafollicular neoplasia to CD30-positive large B cell lymphoma. Immunoglobulin K deleting element (IgKde) and cytogenetic identity between both phases was demonstrated. The patient was in partial response after four cycles of rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP).

CONCLUSIONS

CD30 expression was found to be associated in these cases to the transformation event and could be considered a therapeutic target to add to conventional immunochemotherapeutic regimens, even in combination with auto-SCT. We suggest looking for CD30 expression in transformed follicular lymphoma cases.

摘要

目的

本文报告两例滤泡性淋巴瘤转化为CD30阳性弥漫性大B细胞淋巴瘤的病例,并对该主题的文献进行综述。

结果

第一例代表传统低级别滤泡性淋巴瘤早期转化为CD30阳性大B细胞淋巴瘤的病例。两个成分之间证实了免疫球蛋白(Ig)H和细胞遗传学一致性。应用了高剂量和自体干细胞移植(SCT)并实现了完全缓解。第二例代表滤泡内肿瘤形成突然转化为CD30阳性大B细胞淋巴瘤的病例。两个阶段之间证实了免疫球蛋白K缺失元件(IgKde)和细胞遗传学一致性。患者在接受四个周期的利妥昔单抗联合环磷酰胺、多柔比星、长春新碱和泼尼松(R-CHOP)治疗后部分缓解。

结论

在这些病例中发现CD30表达与转化事件相关,即使与自体SCT联合应用,也可被视为传统免疫化疗方案中增加的一个治疗靶点。我们建议在转化型滤泡性淋巴瘤病例中寻找CD30表达。

相似文献

1
CD 30-positive transformed follicular lymphoma: two case reports and literature review.CD30 阳性转化性滤泡性淋巴瘤:两例报告及文献综述
Histopathology. 2015 Dec;67(6):918-22. doi: 10.1111/his.12733. Epub 2015 Jun 26.
2
The expression of CD30 based on immunohistochemistry predicts inferior outcome in patients with diffuse large B-cell lymphoma.基于免疫组织化学的CD30表达预示弥漫性大B细胞淋巴瘤患者预后较差。
PLoS One. 2015 May 14;10(5):e0126615. doi: 10.1371/journal.pone.0126615. eCollection 2015.
3
[Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: clinicopathologic characterization of 16 cases showing different patterns].[具有弥漫性大B细胞淋巴瘤和经典霍奇金淋巴瘤之间特征的灰色地带淋巴瘤:16例呈现不同模式病例的临床病理特征]
Zhonghua Bing Li Xue Za Zhi. 2014 May;43(5):307-12.
4
Standard R-CHOP therapy in follicular lymphoma and diffuse large B-cell lymphoma.滤泡性淋巴瘤和弥漫性大B细胞淋巴瘤的标准R-CHOP疗法。
J Clin Exp Hematop. 2013;53(2):121-5. doi: 10.3960/jslrt.53.121.
5
CD30 expression in de novo diffuse large B-cell lymphoma: a population-based study from British Columbia.初发弥漫性大B细胞淋巴瘤中CD30的表达:一项来自不列颠哥伦比亚省的基于人群的研究。
Br J Haematol. 2014 Dec;167(5):608-17. doi: 10.1111/bjh.13085. Epub 2014 Aug 19.
6
Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphoma.利妥昔单抗90分钟输注给药用于既往未治疗的弥漫性大B细胞淋巴瘤和滤泡性淋巴瘤患者的III期安全性研究。
Leuk Lymphoma. 2014 Oct;55(10):2335-40. doi: 10.3109/10428194.2013.877135. Epub 2014 Mar 7.
7
CD5-positive follicular lymphoma: a case report and literature review.CD5 阳性滤泡性淋巴瘤:一例报告及文献复习
Intern Med. 2011;50(8):899-904. doi: 10.2169/internalmedicine.50.4339. Epub 2011 Apr 15.
8
Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.来那度胺联合 R-CHOP 方案治疗滤泡性淋巴瘤转化的弥漫性大 B 细胞淋巴瘤新诊患者的疗效:来自 2 期 MC078E 研究的结果。
Blood Cancer J. 2021 Sep 25;11(9):160. doi: 10.1038/s41408-021-00542-z.
9
Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.外周血淋巴细胞/单核细胞比值可预测利妥昔单抗时代滤泡性淋巴瘤和弥漫性大B细胞淋巴瘤患者的预后。
Clin Lymphoma Myeloma Leuk. 2015 Apr;15(4):208-13. doi: 10.1016/j.clml.2014.10.001. Epub 2014 Oct 23.
10
Asymptomatic gastrosplenic fistula in a patient with marginal zonal lymphoma transformed to diffuse large B cell lymphoma--a case report and review of literature.边缘带淋巴瘤转化为弥漫性大B细胞淋巴瘤患者的无症状胃脾瘘——病例报告及文献复习
Ann Hematol. 2014 Sep;93(9):1599-602. doi: 10.1007/s00277-013-1986-8. Epub 2013 Dec 21.

引用本文的文献

1
Development of follicular lymphoma after treatment of diffuse large B-cell lymphoma: two case reports with review of literature.弥漫性大B细胞淋巴瘤治疗后发生滤泡性淋巴瘤:两例报告并文献复习
Int J Clin Exp Pathol. 2018 Jan 1;11(1):324-332. eCollection 2018.